DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis
Author(s) -
Kareem L. Graham,
Bonnie J. Werner,
Kimberly M. Moyer,
Alycia K. Patton,
Charles R. Krois,
Hong Sik Yoo,
Maria Tverskoy,
Melissa LaJevic,
Joseph L. Napoli,
Raymond A. Sobel,
Brian A. Zabel,
Eugene C. Butcher
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1817669116
Subject(s) - experimental autoimmune encephalomyelitis , immunology , inflammation , encephalomyelitis , multiple sclerosis , biology , adoptive cell transfer , t cell , retinoic acid , chemistry , immune system , cell culture , genetics
Significance Multiple sclerosis (MS) is a demyelinating disease of the CNS. Experimental autoimmune encephalomyelitis (EAE) is an animal model that has many similarities to MS. CNS-infiltrating, myelin-reactive T cells have pivotal roles in EAE/MS pathology, but the mechanisms governing pathogenic T cell function within the CNS remain poorly understood. Diacylglycerol O-acyltransferase-1 (DGAT1) is a normal lipid- and retinoid-metabolizing enzyme, but little is known about its role in T cells. We show that EAE is reduced in DGAT1-deficient mice. Moreover, our data suggest that T cell expression of DGAT1, by sequestering retinol, limits regulatory T cell (Treg) formation. Overall, our results implicate DGAT1 as a metabolic modulator of Treg induction, and add to the growing appreciation of the interplay between immunity and metabolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom